DXB 2.63% 55.5¢ dimerix limited

Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-49

  1. 1,194 Posts.
    lightbulb Created with Sketch. 119
    Thank you OvF

    Lets hope so and given that a relatively significant number of patients stayed on the drug post ph2 trials, then the more the merrier.

    I’m sweating on the Covid results due any day now.

    Not getting any younger!

    cheers
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
-0.015(2.63%)
Mkt cap ! $305.1M
Open High Low Value Volume
56.0¢ 58.5¢ 54.0¢ $3.231M 5.779M

Buyers (Bids)

No. Vol. Price($)
1 1118 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.5¢ 239062 1
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.